Hyperprolactinemic Anovulatory Syndrome

  • H. G. Bohnet
Conference paper


In practically all appearances hyperprolactinemia is identical to disturbed follicle maturation and disturbed menstrual cycle, it is therefore classified as a type of hyperprolactinemic anovulatory syndrome. The previous classifications depending on the presence or absence of a pituitary adenoma are no longer necessary, since diagnostic and therapeutic proceedings are the same in both cases.


Luteinizing Hormone Pituitary Adenoma Luteal Phase Premenstrual Syndrome Hyperprolactinemic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ben-David M, Schenker JG (1983) Transient hyperprolactinemia: a correctable cause of idiopathic female infertility. J Clin Endocrinol Metab 57:442PubMedCrossRefGoogle Scholar
  2. 2.
    Berg D, Rjosk H-K, Jänicke F, von Werder K (1983) Behandlung der hyperprolaktinämischen Amenorrhoe durch pulsatile Gaben von Gonadotropin Releasing-Hormonen. Geburtshilfe Frauenheilkd 43:686–688PubMedCrossRefGoogle Scholar
  3. 3.
    Biller BMK, Baum HBA, Rosenthal DI, Saxe VC, Charpie PM, Klibanski A (1992) Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 75:692–697PubMedCrossRefGoogle Scholar
  4. 4.
    Bohnet HG (1980) Gelbkörperschwäche als Prolaktin-bedingte Störung des Menstruationszyklus. Fortschr Med 98:1628Google Scholar
  5. 5.
    Bohnet HG (1981) Prolaktin und seine Bedeutung für die Frau. Grosse, BerlinGoogle Scholar
  6. 6.
    Bohnet HG (1985) Prolaktin und weibliche Sterilität. Leitfaden für die Praxis. Grosse, BerlinGoogle Scholar
  7. 7.
    Bohnet HG, Aragona C, Friesen HG (1976) Induction of lactogenic receptors in the liver of hypophysectomized female rats. Endocrin Res Commun 3:187CrossRefGoogle Scholar
  8. 8.
    Bohnet HG, Dahlen HG, Wuttke W, Schneider HPG (1976) Hyperprolactinemic anovulatory syndrome. J Clin Endocrinol Metab 42:132–143PubMedCrossRefGoogle Scholar
  9. 9.
    Bohnet HG, Mühlenstedt D, Hanker J, Schneider HPG (1977) Prolactin oversuppression. Arch Gynak 223:173–178CrossRefGoogle Scholar
  10. 10.
    Bohnet HG, Kato K (1987) Evaluation of basal hormone levels in hirsute women. Exp Clin Endocrinol 89/1:31–38CrossRefGoogle Scholar
  11. 11.
    Corenblum B, Donovan L (1993) The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fert Steril 59/3:671–673Google Scholar
  12. 12.
    DeWitt W, Coelingh Bennink HJT, Gerards LJ (1984) Prophylactic bromocriptine treatment during pregnancy in women with macroprolactinomas: report of 13 pregnancies. Br J Obstet Gynecol 91:1059CrossRefGoogle Scholar
  13. 13.
    Fahlbusch R, Giovanelli MA, Crosignani PG, Faglia G, Rjosk JK, von Werder K (1980) Differential therapy of microprolactinomas: significance of transphenoidal adenomectomy. In: Faglia G, Giovanelli MA, MacLeod RM (eds) Pituitary microadenomas. Academic, London, pp 443–456Google Scholar
  14. 14.
    Fink U, Fink BK, Oeckler R (1990) MRI versus CT imagine. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds) Pituitary adenomas. Excerpta Medica, Amsterdam, pp 229–236 (ICS 961)Google Scholar
  15. 15.
    Gemzell C, Wang CF (1979) Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 31:363–372PubMedGoogle Scholar
  16. 16.
    Holmgren U, Bergstrand G, Hagenfeldt K, Werner S (1986) Women with prolactinoma-effect of pregnancy and lactation on serum prolactin and on tumor growth. Acta Endocrinol 111:452PubMedGoogle Scholar
  17. 17.
    Katznelson L, Alexander JM, Klibanski A (1993) Clinical review 45. Clinically non-functioning pituitary adenomas. J Clin Endocrinol Metab 76:1089–1094PubMedCrossRefGoogle Scholar
  18. 18.
    Krupp P, Monka C (1987) Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 65:823–827PubMedCrossRefGoogle Scholar
  19. 19.
    Labhart A (1978) Die Adenohypophyse. In: Lebhart A (ed) Klinik der inneren Sekretion. Springer, Berlin Heidelberg New York, p 102Google Scholar
  20. 20.
    Laws ER Jr, Fode NC, Randall RV, Abboud CF, Coulam CB (1983) Pregnancy following transphenoidal resection of prolactin-secreting pituitary tumors. J Neurosurs 58:685–688CrossRefGoogle Scholar
  21. 21.
    Lüdecke DK, Quak C, Saeger W (1992) Intraoperative biopsies and prolactin-IRMA in prolactinomas. Endocrin Pathol 3[Suppl 1]:527Google Scholar
  22. 22.
    Magyar DM, Marshall JR (1978) Pituitary tumors and pregnancy. Am J Obstet Gynecol 132:739–751PubMedGoogle Scholar
  23. 23.
    McNatty KP (1979) Follicular determinants of corpus luteum function in the human ovary. In: Channing CP, Marsh JM (eds) Ovarian follicular and corpus luteum function. Plenum, New York, p 465Google Scholar
  24. 24.
    Molitch ME (1985) Pregnancy and the hyperprolactinemic women. N Engl J Med 312:1362CrossRefGoogle Scholar
  25. 25.
    Niemann D (1985) Wechselbeziehungen zwischen der Regulation der Schilddrüsenfunktion und der Prolaktionsekretion und ihre Bedeutung für Frauen mit Infertilität oder Zyklusstörungen. Dissertation, University of HamburgGoogle Scholar
  26. 26.
    Rjosk H-K, Fahlbusch R, Huber H, von Werder K (1978) Growth of prolactin-producing pituitary adenomas during pregnancy. In: Fahlbusch R, von Werder K (eds) Treatment of pituitary adenomas. Thieme, Stuttgart, p 395Google Scholar
  27. 27.
    Rjosk H-K, Fahlbusch R, von Werder K (1982) Influence of pregnancies on prolactinomas. Acta Endocrinol (Copenh) 100:337–346Google Scholar
  28. 28.
    Rjosk H-K, Fahlbusch R, von Werder K Spontaneous development of hyperprolactinemia. Acta Endocrinol (Copenh) 100:333–336Google Scholar
  29. 29.
    Ruiz-Velasco V, Tolis G (1984) Pregnancy in hyperprolactinemic women. Fertil Steril 41:793PubMedGoogle Scholar
  30. 30.
    Schlechte J, Walkner L, Kathol M (1992) A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. J Clin Endocrinol Metab 75:698–703PubMedCrossRefGoogle Scholar
  31. 31.
    Schneider HPG, Bohnet HG (1977) Hyperprolaktinämische Amenorrhoe and Anovulation. Gynäkologie 10:84Google Scholar
  32. 32.
    Schneider HPG, Bohnet HG (1981) Die hyperprolaktinämische Amenorrhoe und Anovulation. Gynäkologe 14:104PubMedGoogle Scholar
  33. 33.
    Strauß B, Appelt H, Bohnet HG, Quitmann S, Ulrich D (1988) Untersuchungen zur Psychoendokrinologie des Prolaktins. In: Appelt H, Strauß B (eds) Psychoendokrinologische Gynäkologie. Enke, Stuttgart, pp 147–167 (Bücherei des Frauenarztes, vol 18)Google Scholar
  34. 34.
    Tucker HSG, Grubb SR, Wigand JP, Taylor A, Lankford HV, Blackard WG, Becker DP (1981) Galactorrhea-amenorrhea syndrome. Follow-up of forty-five patients after pituitary tumor removal. Ann Intern Med 94:302–307PubMedGoogle Scholar
  35. 35.
    von Werder K, Müller OA, Fink U (1988) Medikamentöse Therapie der Prolaktinome. Akt Endokr Stoffw 9:213–220Google Scholar
  36. 36.
    von Werder K, Müller OA, Fink U, Graef K (1993) Diagnosis and treatment of hyperprolactinemia. In: Comprehensive endocrinology. The pituitary gland, 2nd edn. Raven, New YorkGoogle Scholar
  37. 37.
    Willig RP, Bosk A, Lüdecke DK (1992) Prolactin secreting pituitary adenoma: distinct symptoms in the paediatric age group. Acta Endocrinol 126[Suppl 4]:62Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • H. G. Bohnet

There are no affiliations available

Personalised recommendations